PND8 - PEGINTERFERON BETA-1A IS ASSOCIATED WITH REDUCED RELAPSE RATES AND HOSPITALISATIONS DUE TO RELAPSE COMPARED WITH OTHER FIRST-LINE INJECTABLE THERAPIES FOR MULTIPLE SCLEROSIS- FINDINGS FROM A REAL-WORLD CROSS-SECTIONAL STUDY

Oct 1, 2018, 00:00
10.1016/j.jval.2018.09.1975
https://www.valueinhealthjournal.com/article/S1098-3015(18)35277-X/fulltext
Title : PND8 - PEGINTERFERON BETA-1A IS ASSOCIATED WITH REDUCED RELAPSE RATES AND HOSPITALISATIONS DUE TO RELAPSE COMPARED WITH OTHER FIRST-LINE INJECTABLE THERAPIES FOR MULTIPLE SCLEROSIS- FINDINGS FROM A REAL-WORLD CROSS-SECTIONAL STUDY
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(18)35277-X&doi=10.1016/j.jval.2018.09.1975
First page :
Section Title :
Open access? : No
Section Order : 1334
Categories :
Tags :
Regions :
ViH Article Tags :